Literature DB >> 33841594

Usefulness of electron microscopy in the diagnosis of wild-type transthyretin cardiac amyloidosis.

Isamu Sunayama1, Takahiro Yoshimura1, Takuryu Sonoura1, Yuka Nakamura1, Yu Morishita1, Takayuki Sekihara1, Masashi Ishimi1, Masashi Yamato1, Yoshihiko Hoshida2, Yoshinori Yasuoka1.   

Abstract

Wild-type transthyretin cardiac amyloidosis (ATTRwt) has been recognized as an important cause of heart failure with preserved ejection fraction; thus, its accurate diagnosis is crucial. Herein, we describe the case of a 76-year-old man who presented with dyspnea and palpitation. On observing the laboratory evaluations and clinical course, we suspected cardiac amyloidosis. However, optical microscopic analysis by Congo-red and direct fast scarlet staining revealed no amyloid deposits in the biopsy samples. Therefore, a more thorough investigation was pursued by examining the myocardial tissue under electron microscopy. We could recognize amyloid deposits between the myocardial fibers using electron microscopy. We submitted all the pathological specimens to a specialized facility for genetic testing to ensure the accurate diagnosis of the amyloidosis disease type. As a result, a biopsy sample from the minor salivary gland was stained with the Congo red stain. Anti-transthyretin antibody detected using immunohistochemical analysis of amyloidosis supported the presence of transthyretin form of amyloid proteins. Genetic testing revealed the absence of TTR gene mutations. The final diagnosis was ATTRwt. We believe that this case suggests the usefulness of electron microscopy in the diagnosis of ATTRwt and other related disorders. Further study is warranted to validate our findings.
© 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnostic strategies; Electron microscopy; Heart failure; Preserved ejection fraction; Transthyretin cardiac amyloidosis

Year:  2021        PMID: 33841594      PMCID: PMC8020065          DOI: 10.1016/j.jccase.2020.11.023

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Electron microscopy in patients with clinically suspected of cardiac amyloidosis who underwent endomyocardial biopsy and negative Congo red staining.

Authors:  Zhongwei Cheng; Quancai Cui; Zhuang Tian; Dachun Zhao; Kongbo Zhu; Quan Fang
Journal:  Int J Cardiol       Date:  2013-05-03       Impact factor: 4.164

2.  Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis.

Authors:  Nicole B Cyrille; Jeff Goldsmith; Julissa Alvarez; Mathew S Maurer
Journal:  Am J Cardiol       Date:  2014-07-18       Impact factor: 2.778

Review 3.  [Amyloidosis. Also a heart disease].

Authors:  Pablo García-Pavía; María Teresa Tomé-Esteban; Claudio Rapezzi
Journal:  Rev Esp Cardiol       Date:  2011-07-19       Impact factor: 4.753

4.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

Authors:  Esther González-López; Maria Gallego-Delgado; Gonzalo Guzzo-Merello; F Javier de Haro-Del Moral; Marta Cobo-Marcos; Carolina Robles; Belén Bornstein; Clara Salas; Enrique Lara-Pezzi; Luis Alonso-Pulpon; Pablo Garcia-Pavia
Journal:  Eur Heart J       Date:  2015-07-28       Impact factor: 29.983

5.  Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

Authors:  Claudio Rapezzi; Giampaolo Merlini; Candida C Quarta; Letizia Riva; Simone Longhi; Ornella Leone; Fabrizio Salvi; Paolo Ciliberti; Francesca Pastorelli; Elena Biagini; Fabio Coccolo; Robin M T Cooke; Letizia Bacchi-Reggiani; Diego Sangiorgi; Alessandra Ferlini; Michele Cavo; Elena Zamagni; Maria Luisa Fonte; Giovanni Palladini; Francesco Salinaro; Francesco Musca; Laura Obici; Angelo Branzi; Stefano Perlini
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

6.  Diagnostic approach to cardiac amyloidosis.

Authors:  Hilman Zulkifli Amin; Shumpei Mori; Naoto Sasaki; Kenichi Hirata
Journal:  Kobe J Med Sci       Date:  2014-06-18

Review 7.  Transthyretin (TTR) cardiac amyloidosis.

Authors:  Frederick L Ruberg; John L Berk
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

8.  Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations.

Authors:  Per Westermark; Joakim Bergström; Alan Solomon; Charles Murphy; Knut Sletten
Journal:  Amyloid       Date:  2003-08       Impact factor: 7.141

9.  Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Authors:  Mathew S Maurer; Jeffrey H Schwartz; Balarama Gundapaneni; Perry M Elliott; Giampaolo Merlini; Marcia Waddington-Cruz; Arnt V Kristen; Martha Grogan; Ronald Witteles; Thibaud Damy; Brian M Drachman; Sanjiv J Shah; Mazen Hanna; Daniel P Judge; Alexandra I Barsdorf; Peter Huber; Terrell A Patterson; Steven Riley; Jennifer Schumacher; Michelle Stewart; Marla B Sultan; Claudio Rapezzi
Journal:  N Engl J Med       Date:  2018-08-27       Impact factor: 91.245

10.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

  10 in total
  1 in total

1.  Application of CT Scan in Diagnosis of Iliac-Femoral Vein Thrombosis after Hip Replacement.

Authors:  Dong Li; Lishan Wang; Zhanxin Li; Libin Li; Qingwei Wang; Li Zhang; Zhigang Guo
Journal:  Scanning       Date:  2022-06-20       Impact factor: 1.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.